祖三问
Lv4
426 积分
2021-10-27 加入
-
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
4天前
已完结
-
Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial
7天前
已完结
-
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study
2个月前
已完结
-
重症患者应激性消化道出血及其对预后的影响
5个月前
已关闭
-
Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects
6个月前
已完结
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
6个月前
已完结
-
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
6个月前
已完结
-
注射用艾普拉唑钠和艾司奥美拉唑钠预防消化性溃疡再出血的有效性和安全性对照研究
6个月前
已完结
-
Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding — An Updated Meta-Analysis
7个月前
已完结
-
Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation
7个月前
已完结